Cargando…

Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction

BACKGROUND: A link between angina with no obstructive coronary artery disease (CAD) and heart failure with preserved left ventricular ejection fraction has been proposed, but evidence in support of this is lacking. In a cross-sectional study, we investigated whether left ventricular diastolic functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelsen, Marie Mide, Pena, Adam, Mygind, Naja D., Høst, Nis, Gustafsson, Ida, Hansen, Peter Riis, Hansen, Henrik Steen, Kastrup, Jens, Prescott, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532855/ https://www.ncbi.nlm.nih.gov/pubmed/31120897 http://dx.doi.org/10.1371/journal.pone.0216240

Ejemplares similares

Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study
por: Mygind, Naja Dam, et al.
Publicado: (2016)

Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction
por: Schroder, Jakob, et al.
Publicado: (2019)

Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial
por: Michelsen, Marie Mide, et al.
Publicado: (2018)

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?
por: Suhrs, Hannah E., et al.
Publicado: (2020)

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms
por: Bove, Kira Bang, et al.
Publicado: (2021)

Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study
por: Mygind, Naja Dam, et al.
Publicado: (2016)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
por: Faber, Rebekka, et al.
Publicado: (2015)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

A Case of Postpartum Pulmonary Edema With Preserved Ejection Fraction and Diastolic Capacity
por: Tanabe, Shohei, et al.
Publicado: (2022)

Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
por: Frisk, Michael, et al.
Publicado: (2021)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction
por: Fuchida, Aya, et al.
Publicado: (2021)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction
por: Kim, Myung Yoon, et al.
Publicado: (2023)

Diastolic dysfunction in patients with preserved ejection fraction: identification by velocity encoded magnetic resonance imaging
por: Radunski, Ulf K, et al.
Publicado: (2011)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng, Huan, et al.
Publicado: (2014)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
por: Coculescu, Bogdan Ioan, et al.
Publicado: (2018)

Left Atrial Size and Heart Failure Hospitalization in Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Issa, Omar, et al.
Publicado: (2017)

Heart Failure With Preserved Ejection Fraction　― Time for a Paradigm Shift Beyond Diastolic Function ―
por: Oki, Takashi, et al.
Publicado: (2018)

Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Prognostic utility of diastolic dysfunction and speckle tracking echocardiography in heart failure with reduced ejection fraction
por: Hansen, Sune, et al.
Publicado: (2019)

Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction
por: Liu, Dan, et al.
Publicado: (2014)

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019)

Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction
por: Karagodin, Ilya, et al.
Publicado: (2017)

Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
por: Neves, João Sérgio, et al.
Publicado: (2020)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Verbrugge, Frederik H, et al.
Publicado: (2021)

Visualizing diastolic failure: Non-invasive imaging-biomarkers in patients with heart failure with preserved ejection fraction
por: Schulz, Alexander, et al.
Publicado: (2022)

Diagnosis of Heart Failure With Preserved Ejection Fraction Relies on Detection of Increased Diastolic Filling Pressure, But How?
por: Oh, Jae K., et al.
Publicado: (2023)

Due Diligence of a Diastolic Index as a Prognostic Factor in Heart Failure with Preserved Ejection Fraction
por: Hoshida, Shiro
Publicado: (2023)

Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic Ejection Fraction
por: Gu, Haotian, et al.
Publicado: (2017)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
por: Chou, Ruey-Hsing, et al.
Publicado: (2016)

Left Ventricular Torsion Shear Angle Volume Approach for Noninvasive Evaluation of Diastolic Dysfunction in Preserved Ejection Fraction
por: Sharifov, Oleg F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fj0kaqoagl2qakh62000q88mhc